Journal of Materials Chemistry B · 2020 · 58 citations · 45 references
PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineInorganic NanoparticlesNanocompositesNanomedicineNanoparticle Delivery SystemsPhotothermal TherapyAnticancer Drug LoadingCancer NanotherapyCancer Photothermal TherapyMultifunctional NanoplatformsNanoparticle DeliveryPhotothermal Conversion EfficiencyPhotothermal EffectsTumor-targeted Drug Delivery
) and a greater photothermal conversion efficiency (η = 42.7%) than CuS/PDA alone. The uptake of CuS@PDA-FA/DOX nanocomposites is much higher in MCF-7 cells than in A549 cells because MCF-7 cells have much higher folic acid receptors than A549. Under near infrared (NIR) irradiation, the CuS@PDA-FA/DOX system using a synergistic combination of photothermal therapy and chemotherapy yields a better therapeutic effect than either photothermal therapy or chemotherapy alone. The treatment is very effective with the cell viability is only 5.6 ± 1.4%.
45
Bernard Fisher, Stewart Anderson, John Bryant et al. · New England Journal of Medicine · 2002 · 6.2K citations · Full text
Teng Liu, Chao Wang, Xing Gu et al. · Advanced Materials · 2014 · 1.2K citations
Pharmacy, Oncology, Pharmaceutics +17
Jianwei Fu, Zhonghui Chen, Minghuan Wang et al. · Chemical Engineering Journal · 2014 · 1.1K citations
Engineering, Chemical Engineering, Environmental Engineering +15